Skip to main content
Clinical Trials/NCT02098577
NCT02098577
Completed
N/A

Effect of Two Different Rehabilitation Programs on Balance in Parkinsonian Patients: Crossover Versus Stabilometric Platform

Ospedale Generale Di Zona Moriggia-Pelascini1 site in 1 country60 target enrollmentJune 2013

Overview

Phase
N/A
Intervention
Not specified
Conditions
Parkinson's Disease
Sponsor
Ospedale Generale Di Zona Moriggia-Pelascini
Enrollment
60
Locations
1
Primary Endpoint
BBS
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

The aims of this study is to assess the efficacy of the crossover on balance in Parkinsonian patients and compare this results with the results of a control group of patients treated with a stabilometric platform.

Detailed Description

Parkinson's disease (PD) is a neurodegenerative disorder characterized by different motor symptoms (rigidity, akinesia, tremor and impairment of balance and gait). Even though pharmacological treatment has changed the natural course of the disease, balance worsens over time and leads to falls. The aims of this study is to assess the efficacy of the crossover (group 1) on balance in Parkinsonian patients and compare this results with the results of a control group of patients treated with a stabilometric platform (group 2). The group 1 executed 6 days/week for a 4-weeks cycle a crossover protocol based on the first 4 level of resistance and a training which lasts at most 5 minutes. The group 2 executed 6 days/week for a 4-weeks cycle different exercises with the stabilometric platform in monopodalic and in bipodalic standing.

Registry
clinicaltrials.gov
Start Date
June 2013
End Date
February 2014
Last Updated
12 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Ospedale Generale Di Zona Moriggia-Pelascini
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • PD in stage III Hoen\&Yahr according to Gelb et la. with the ability to walk without any assistance and with Mini Mental State Examination (MMSE) score \> 26

Exclusion Criteria

  • MMSE \< 26
  • Coexistence of other neurological diseases
  • PD patients with relevant orthopedic, rheumatic and muscular conditions

Outcomes

Primary Outcomes

BBS

Time Frame: One month

Berg Balance Scale

Secondary Outcomes

  • 6MWT(One month)
  • TUG(One month)
  • UPDRS II(One month)
  • UPDRS III(One month)

Study Sites (1)

Loading locations...

Similar Trials